Informations techniques
Exploitant
Laboratoires PROSTRAKAN PHARMA
Présentation
DROLEPTAN 2,5 mg/ 1ml, solution injectable (IV) B/10 - CIP 561 122-8
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
VU8Z8ELtAT2Udetq